Law360 (March 6, 2019, 11:06 PM EST) -- Scott Gottlieb didn’t shy away from publicly calling on e-cigarette companies to address youth vaping or from telling drug companies to quit anti-competitive practices during his tenure as head of the U.S. Food and Drug Administration, shining a light on key issues.
Gottlieb, who is leaving in a month, brought an energetic, pragmatic approach to tackling problems such as the opioid crisis, and his public presence — from media appearances to speeches to his frequent use of Twitter — spotlighted the FDA's activities and limitations, attorneys said.
In a tumultuous administration marked by sudden ousters, Gottlieb also managed to stay in...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!